Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: Report of two cases

Multiple Sclerosis

Volumn 13, Issue 5, 2007, Pages 676-678

  Portaccio, Emilio ^a   Amato, M P ^a   Siracusa, G ^a   Pagliai, F ^b   Sorbi, S ^a   Guidi, S ^b   Bosi, A ^b   Saccardi, R ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Autologous stem cell transplantation; Multiple sclerosis

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LYMPHOCYTE ANTIBODY; METHOTREXATE; MITOXANTRONE;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RELAPSE; REMISSION; STEM CELL MOBILIZATION;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 34250648076     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506073502     Document Type: Article

References (9)

1. Blanco Y, Saiz A, Carreras E, Graus F. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol 2005; 4: 54-63.
2. Fassas A, Kimiskidis VK. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience. J Neurol Sci 2004; 223: 53-58.
3. Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A, Inglese M et al. and the Italian GITMO-NEURO Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 2001; 57: 62-68.
4. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-ingoni R et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805-16.
5. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. for the Italian GITMO-Neuro Intergroup. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601-607.
6. Burt RK, Cohen BA, Lobeck L, Traynor AE, Bredeson C. Autologous hematopoietic stem cell transplantation in multiple sclerosis: importance of disease stage on outcome. Neurology 2003; 5: A150.
7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
8. Comi G, Kappos L, Clanet M, Ebers G, Fassas A, Fazekas F et al. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. J Neurol 2000; 247: 376-82.
9. Saiz A, Carreras E, Berenguer J, Yague J, Martinez C, Marin P et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 2001; 56: 1084-89.